Lack of association between measles virus vaccine and autism with enteropathy: A case-control study

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Hornig, Mady ^a   Briese, Thomas ^a   Buie, Timothy ^b   Bauman, Margaret L ^b   Lauwers, Gregory ^b   Siemetzki, Ulrike ^a   Hummel, Kimberly ^c   Rota, Paul A ^c   Bellini, William J ^c   O'Leary, John J ^d   Sheils, Orla ^d   Alden, Errol ^e   Pickering, Larry ^f   Lipkin, W Ian ^a  

^a Columbia University ^*  (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e AMERICAN ACADEMY OF PEDIATRICS   (United States)

^f NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; VIRUS RNA;

ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; ENTEROPATHY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; ILEUM; IMMUNIZATION; MALE; MEASLES; MUMPS; PERIODICITY; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUBELLA; SINGLE BLIND PROCEDURE; BEHAVIOR; FAMILY HEALTH; GASTROINTESTINAL DISEASE; INTESTINE; METABOLISM; NEUROPSYCHOLOGICAL TEST; PRESCHOOL CHILD; VIROLOGY;

MEASLES VIRUS; RUBELLA;

AUTISTIC DISORDER; BEHAVIOR; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INTESTINES; MALE; MEASLES VACCINE; NEUROPSYCHOLOGICAL TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 52149120139     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003140     Document Type: Article

References (49)

1. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, et al. (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351: 637-641.
2. Ashwood P, Anthony A, Torrente F, Wakefield AJ (2004) Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 24: 664-673.
3. Ashwood P, Wakefield AJ (2006) Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 173: 126-134.
4. Furlano RI, Anthony A, Day R, Brown A, McGarvey L, et al. (2001) Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 138: 366-372.
5. Torrente F, Ashwood P, Day R, Machado N, Furlano RI, et al. (2002) Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7: 375-382, 334.
6. Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, et al. (2000) Enterocolitis in children with developmental disorders. Am J Gastroenterol 95: 2285-2295.
7. Wakefield AJ, Ashwood P, Limb K, Anthony A (2005) The significance of ileocolonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol 17: 827-836.
8. Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, et al. (2003) Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 23: 504-517.
9. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, et al. (2000) Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci 45: 723-729.
10. Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, et al. (2002) Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 55: 84-90.
11. Wakefield AJ (2002) Enterocolitis, autism and measles virus. Mol Psychiatry 7 Suppl 2: S44-46.
12. O'Leary JJ, Uhlmann V, Wakefield AJ (2000) Measles virus and autism. Lancet 356: 772.
13. Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, et al. (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345: 656-661.
14. Chen W, Landau S, Sham P, Fombonne E (2004) No evidence for links between autism, MMR and measles virus. Psychol Med 34: 543-553.
15. Dales L, Hammer SJ, Smith NJ (2001) Time trends in autism and in MMR immunization coverage in California. JAMA 285: 1183-1185.
16. DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C (2004) Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics 113: 259-266.
17. Farrington CP, Miller E, Taylor B (2001) MMR and autism: further evidence against a causal association. Vaccine 19: 3632-3635.
18. Fombonne E, Chakrabarti S (2001) No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 108: E58.
19. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D (2006) Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 118: e139-150.
20. Honda H, Shimizu Y, Rutter M (2005) No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry 46: 572-579.
21. Kaye JA, del Mar Melero-Montes M, Jick H (2001) Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 322: 460-463.
22. Lingam R, Simmons A, Andrews N, Miller E, Stowe J, et al. (2003) Prevalence of autism and parentally reported triggers in a north east London population. Arch Dis Child 88: 666-670.
23. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, et al. (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347: 1477-1482.
24. Makela A, Nuorti JP, Peltola H (2002) Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110: 957-963.
25. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, et al. (2000) Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 19: 1127-1134.
26. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, et al. (1998) No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 351: 1327-1328.
27. Richler J, Luyster R, Risi S, Hsu WL, Dawson G, et al. (2006) Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study. J Autism Dev Disord 36: 299-316.
28. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, et al. (2004) MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 364: 963-969.
29. Smeeth L, Hall AJ, Fombonne E, Rodrigues LC, Huang X, et al. (2001) A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. BMC Public Health 1: 2.
30. Takahashi H, Arai S, Tanaka-Taya K, Okabe N (2001) Autism and infection/ immunization episodes in Japan. Jpn J Infect Dis 54: 78-79.
31. Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, et al. (1999) Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 353: 2026-2029.
32. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, et al. (2002) Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 324: 393-396.
33. Uchiyama T, Kurosawa M, Inaba Y (2007) MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan. J Autism Dev Disord 37: 210-217.
34. Afzal MA, Ozoemena LC, O'Hare A, Kidger KA, Bentley ML, et al. (2006) Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol 78: 623-630.
35. D'Souza Y, Fombonne E, Ward BJ (2006) No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics 118: 1664-1675.
36. Baird G, Pickles A, Simonoff E, Charman T, Sullivan P, et al. (2008) Measles vaccination and antibody response in autism spectrum disorders. Arch Dis Child (epub ahead of print).
37. American Academy of Pediatrics Committee on Infectious Diseases (2008) Recommended immunization schedules for children and adolescents - United States, 2008. Pediatrics 121: 219-220.
38. Klagge IM, Abt M, Fries B, Schneider-Schaulies S (2004) Impact of measles virus dendritic-cell infection on Th-cell polarization in vitro. J Gen Virol 85: 3239-3247.
39. Rima BK, Duprex WP (2006) Morbilliviruses and human disease. J Pathol 208: 199-214.
40. Luyster R, Richler J, Risi S, Hsu WL, Dawson G, et al. (2005) Early regression in social communication in autism spectrum disorders: a CPEA Study. Dev Neuropsychol 27: 311-336.
41. O'Leary JJ (2003) Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 56: 248.
42. Wakefield AJ, Puleston JM, Montgomery SM, Anthony A, O'Leary JJ, et al. (2002) Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther 16: 663-674.
43. Wakefield AJ, Montgomery SM (2000) Measles, mumps, rubella vaccine: through a glass, darkly. Adverse Drug React Toxicol Rev 19: 265-283; discussion 284-292.
44. APA (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Fourth Edition, Text Revision ed. Arlington: American Psychiatric Association.
45. Lord C, Rutter M, Le Couteur A (1994) Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24: 659-685.
46. Fenson L (1989) The MacArthur Communicative Development Inventory: Infant and Toddler Versions. San Diego, CA: San Diego State University.
47. Molloy CA, Morrow AL, Meinzen-Derr J, Dawson G, Bernier R, et al. (2006) Familial autoimmune thyroid disease as a risk factor for regression in children with Autism Spectrum Disorder: a CPEA Study. J Autism Dev Disord 36: 317-324.
48. Niehus R, Lord C (2006) Early medical history of children with autism spectrum disorders. J Dev Behav Pediatr 27: S120-127.
49. Risi S, Lord C, Gotham K, Corsello C, Chrysler C, et al. (2006) Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 45: 1094-1103.